Position history for HSBC HOLDINGS PLC's holdings in Corvus Pharmaceuticals, Inc.
HSBC HOLDINGS PLC holds 59,269 shares of CRVS (Corvus Pharmaceuticals, Inc.), worth $451,037 as of 2025-Q4. The position was decreased (-28.1% shares). CRVS represents 0.0% of HSBC HOLDINGS PLC's portfolio.
Current Value
$451,037
Current Shares
59,269
Total Value Change
+$118,997
Total Shares Change
-25,004
Other major holders of CRVS: Point72 Asset Management, L.P., BlackRock, Inc., VANGUARD GROUP INC
Decreased |
| 59,269 |
-28.1% |
| $451,037 |
| 0.0% |
| $7.49 |
0 |
| 2025-Q3 | Decreased | 82,387 | -2.2% | $586,595 | 0.0% | $7.28 | 0 |
| 2025-Q2 | New | 84,273 | - | $332,040 | 0.0% | $3.89 | 33 |